Barely Significant
← all excerpts

Efficacy and Safety of Telitacicept in Posttransplant Recurrent IgA Nephropathy.

Kidney Int Rep · 2026 · PMC13127332 · PMID 42064224

Europe PMCDOI
1
hedged sentence
0.0500
closest p · 1.0× alpha
0.0500
boldest claim

The sentences

approached significanceP = 0.050actually significant
The overall time effect of sCD89 approached significance ( P = 0.050).

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.